DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Matulonis UA, Shapira R, Santin A. et al.
Final results from the KEYNOTE-100 trial of pembrolizumab in patients with advanced recurrent ovarian cancer.
J Clin Oncol 2020;
38 (no. 15_suppl): 6005
DOI: 10.1200/JCO.2020.38.15_suppl.6005.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.